Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SOTORASIB for K-ras gene mutation: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 752 adverse event reports in the FDA FAERS database where SOTORASIB was used for K-ras gene mutation.

Most Reported Side Effects for SOTORASIB

Side Effect Reports % Deaths Hosp.
Non-small cell lung cancer 483 16.5% 131 55
Death 319 10.9% 311 19
Disease progression 314 10.7% 83 9
Diarrhoea 284 9.7% 39 62
Off label use 193 6.6% 41 22
Nausea 98 3.4% 16 27
Non-small cell lung cancer metastatic 93 3.2% 33 16
Hepatotoxicity 91 3.1% 16 16
Fatigue 87 3.0% 5 14
Hepatic function abnormal 80 2.7% 12 27
Aspartate aminotransferase increased 71 2.4% 6 19
Alanine aminotransferase increased 70 2.4% 5 17
Lung neoplasm malignant 64 2.2% 17 8
Drug ineffective 62 2.1% 8 5
Decreased appetite 56 1.9% 11 16

Other Indications for SOTORASIB

Non-small cell lung cancer (897) Product used for unknown indication (850) Lung neoplasm malignant (353) Non-small cell lung cancer stage iv (159) Lung adenocarcinoma (104) Non-small cell lung cancer metastatic (70) Lung adenocarcinoma stage iv (39) Colorectal cancer metastatic (35) Off label use (33) Non-small cell lung cancer recurrent (28)

Other Drugs Used for K-ras gene mutation

AMG-510 (173) IRINOTECAN (40) PANITUMUMAB (36) CETUXIMAB (29) PEMBROLIZUMAB (28) BEVACIZUMAB (19) DALOTUZUMAB (18) CARBOPLATIN (17) FLUOROURACIL (17) PEMETREXED (16)

Related Pages

SOTORASIB Full Profile All K-ras gene mutation Drugs SOTORASIB Demographics SOTORASIB Timeline